Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base

Published:2007-08 Issue:2 Volume:178 Page:451-454
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

David Kevin A.¹,Milowsky Matthew I.¹²,Ritchey Jamie³,Carroll Peter R.⁴,Nanus David M.¹²

Affiliation:

1. Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York

2. Department of Urology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York

3. American College of Surgeons, Chicago, Illinois

4. Department of Urology, University of California at San Francisco, San Francisco, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. American Cancer Society Facts and Figures 2006,2006

2. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial 1;Malmstrom;J Urol,1996

3. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

4. Advanced Bladder Cancer Meta-analysis Collaboration: neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis;Lancet,2003

5. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis;Winquist;J Urol,2004

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Neoadjuvant Chemotherapy in Advanced Bladder Cancer;annals of urologic oncology;2024-08-20

2. Prognostic Value of Postneoadjuvant Chemotherapy Neutrophil-to-Lymphocyte Ratio in Patients undergoing Radical Cystectomy;Journal of Clinical Medicine;2024-03-28

3. Regulatory Role of Autophagy and Glucose Metabolic Reprogramming in the Malignant Progression of Bladder Cancer: A Review;annals of urologic oncology;2024-02-15

4. Molecular Biology of Bladder Cancer: A New Insight in Diagnosis and Treatment Management;Interdisciplinary Cancer Research;2024

5. Impact of using novel antitumor drugs in adult patients with locally advanced or metastatic urothelial carcinoma on reducing cancer mortality in Russia;Cancer Urology;2023-11-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3